ArticleFrontiers in molecular biosciences2025
Successful prediction of LC8 binding to intrinsically disordered proteins sheds light on AlphaFold's black box.
Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cooperative multivalency converts disorder into rods, resolving a paradox in cellular architecture.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: LC8 is a hub protein involved in many processes from tumor suppression and cell cycle regulation to neurotransmission and viral infection. Despite recent progress, prediction of binding sites for LC8 is plagued by motif variability and a multitude of weakly binding motifs, especially when binding depends on multivalency. Our binding site prediction algorithm, LC8Pred has proven useful for uncovering new LC8 binders, but is insufficient for finding all LC8 binding sites. Methods: To address this, we probed the ability of a general structure predictor, AlphaFold, to predict whether a given sequence binds to LC8. Certain combinations of in-built AlphaFold scores were extracted and distributions of scores of binders were compared to scores of nonbinders. Results: AlphaFold successfully places proteins at the correct interface of LC8. A set of threshold values of built-in AlphaFold scores enables differentiation between known binders and nonbinders with minimal false positive (8%) and acceptable false negative rates (20%). This cutoff, along with a more inclusive cutoff, was used to predict elusive LC8 binding sites in proteins known to bind LC8. Discussion: Correlations between binding affinities and AlphaFold scores provide insight into the black box and indicate that AlphaFold learned an inaccurate energy function that nevertheless is useful for making inferences and conclusions about physical systems. Binding sites predicted by this method can be prioritized for investigation by comparing to result by LC8Pred, local structure, and evolutionary conservation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.